Hideki Takami

Dr. Hideki Takami

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014
Verified
Journal Article
Closed access
MSMasaya Suenaga
Masaya Suenaga
Tsutomu FujiiTsutomu Fujii
Tsutomu Fujii
MKMitsuro Kanda
Mitsuro Kanda
HTHideki Takami
Hideki Takami
NONorio Okumura
Norio Okumura
YKYasuhiro Kodera
Yasuhiro Kodera

16 September 2015 in International Journal of Oncology
Verified
Journal Article
Open access
HTHaruyoshi Tanaka
Haruyoshi Tanaka
MKMitsuro Kanda
Mitsuro Kanda
MKMasahiko Koike
Masahiko Koike
NINaoki Iwata
Naoki Iwata
DSDai Shimizu
Dai Shimizu
YKYasuhiro Kodera
Yasuhiro Kodera
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications

25 December 2002 in Publications of the Astronomical Society of Japan
Verified
Journal Article
Open access
PDF file
YIYoichi Itoh
Yoichi Itoh
MTMotohide Tamura
Motohide Tamura
SHSaeko S. Hayashi
Saeko S. Hayashi
YOYumiko Oasa
Yumiko Oasa
MFMisato Fukagawa
Misato Fukagawa
MIMasanori Iye
Masanori Iye
The highest angular resolution near-infrared images of the GG Tau A binary system were obtained with the Coronagraphic Imager with Adaptive Optics (CIAO) mounted on the Subaru Telescope. The images show that its circumbinary disk is smooth and does not have $${0\rlap {.}{}^{\mathrm {\prime \prime }}1}$$ scale structures. Asymmetries in the surface brightness as well as a gap are also resolved. Combined with previous measurements of the stellar positions, our data indicate that the central binary is unlikely to have a large eccentricity. The fifth point source toward this double binary system is probably a background star, based on astrometric measurements.

30 June 2015 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
KEKazuhiro Ezaka
Kazuhiro Ezaka
MKMitsuro Kanda
Mitsuro Kanda
HSHiroyuki Sugimoto
Hiroyuki Sugimoto
DSDai Shimizu
Dai Shimizu
HOHisaharu Oya
Hisaharu Oya
YKYasuhiro Kodera
Yasuhiro Kodera

1 September 2020 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
MSMasaya Suenaga
Masaya Suenaga
Tsutomu FujiiTsutomu Fujii
Tsutomu Fujii
SYSuguru Yamada
Suguru Yamada
MHMasamichi Hayashi
Masamichi Hayashi
KSKeiko Shinjo
Keiko Shinjo
YKYasuhiro Kodera
Yasuhiro Kodera

1 September 2017 in BMC Cancer
Verified
Journal Article
Open access
PDF file
SUShinichi Umeda
Shinichi Umeda
MKMitsuro Kanda
Mitsuro Kanda
HSHiroyuki Sugimoto
Hiroyuki Sugimoto
HTHaruyoshi Tanaka
Haruyoshi Tanaka
MHMasamichi Hayashi
Masamichi Hayashi
YKYasuhiro Kodera
Yasuhiro Kodera
Molecular biomarkers capable of predicting recurrence patterns and prognosis are helpful for risk stratification and providing appropriate treatment to patients with hepatocellular carcinoma (HCC). In this study, we focused on G protein-coupled receptor 155 (GPR155), a cell surface signaling protein, as a candidate biomarker. We analyzed GPR155 expression, DNA methylation, and copy number in HCC cell lines. The clinical significance of GPR155 expression was evaluated using 144 pairs of surgically resected liver and normal tissues with subgroup analysis based on hepatitis virus infection. GPR155 mRNA expression levels were differential and were decreased in 89% of HCC cell lines. No DNA methylation was detected, whereas copy number alterations were present in five (56%) HCC cell lines. GPR155 mRNA expression level was independent of background liver status and significantly lower in HCC tissues than corresponding normal liver tissues. The expression patterns of GPR155 protein by immunohistochemical staining were significantly associated with those of GPR155 mRNA. Downregulation of GPR155 was significantly associated with more aggressive HCC phenotypes including high preoperative α-fetoprotein, poor differentiation, serosal infiltration, vascular invasion, and advanced disease stage. Patients with downregulation of GPR155 were more likely to have worse prognosis after curative resection irrespective of hepatitis virus infection. Patients who experienced extrahepatic (distant) recurrences had significantly lower GPR155 expression than those with intrahepatic (liver confined) recurrences. Downregulation of GPR155 may serve as a prognosticator that also predicts initial recurrence sites independent of hepatitis virus infection.